Elevance Health, Inc.
AT ˙ WBAG
SecurityAT:ELV / Elevance Health, Inc.
InstitutionAlta Advisers Ltd
Latest Disclosed Ownership831 shares
Latest Disclosed Value $ 243,275
Alta Advisers Ltd ownership in ELV / Elevance Health, Inc.

On May 7, 2026 - Alta Advisers Ltd filed a 13F-HR form disclosing ownership of 831 shares of Elevance Health, Inc. (AT:ELV) valued at $243,275 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 831 shares of Elevance Health, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 831 0 0.00 243 -16.49 0.0880
2026-02-09 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 831 -240 -22.41 291 -15.90 0.1056
2025-10-31 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 1,071 0 0.00 346 -16.83 0.1058
2025-07-25 2025-06-30 13F ELEVANCE HEALTH COM 036752103 1,071 0 0.00 417 -10.54 0.1483
2025-04-25 2025-03-31 13F ELEVANCE HEALTH COM 036752103 1,071 300 38.91 466 63.73 0.1983
2025-02-14 2024-12-31 13F ELEVANCE HEALTH COM 036752103 771 171 28.50 284 -8.97 0.1796
2024-11-08 2024-09-30 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 312 -4.00 0.1425
2024-08-08 2024-06-30 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 325 4.50 0.1564
2024-04-24 2024-03-31 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 311 10.28 0.1542
2024-02-12 2023-12-31 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 283 8.05 0.1511
2023-11-03 2023-09-30 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 261 -1.88 0.1514
2023-07-25 2023-06-30 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 267 -3.27 0.1500
2023-05-09 2023-03-31 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 276 0.1647
2023-01-27 2022-12-31 13F ELEVANCE HEALTH COM 036752103 600 0 0.00 0 -100.00 0.1844
2022-10-28 2022-09-30 13F ELEVANCE HEALTH COM 036752103 600 600 273 0.1719
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.